Fundraising Fox
🦊/People
Sign in

Kwame Ulmer

Investor

Venture Partner at Wavemaker Three-Sixty Health

Los Angeles, California

Writes $100K – $10M checks · typically $1M

Find your path to Kwame

134 people in our graph share verified history with Kwame — schools, employers, funds. One of them is your warm intro.

Gordon DaughertyunlockedKwame: together at Senseye (2026)
×2Kwame: together at FDA
×9Kwame: together at Wavemaker Three-Sixty Health

About

Kwame Ulmer is a Venture Partner focused on med-tech. He previously held progressive leadership roles at the FDA, including Deputy Director, and served as Vice President at a Danaher Corporation operating company, evaluating over 1,000 FDA applications. He is also Managing Partner at MedTech Impact Partners, founder of MedTech Color, and a lecturer who co-leads med-tech innovation research at UCLA's Anderson School of Management.

Invests in

Digital HealthHealthtechMedical Devices

Experience

  1. MedTech Impact PartnersManaging Partnercurrent2017 — presentGreater Los Angeles Area
  2. Wavemaker Three-Sixty HealthVenture Partnercurrent2018 — presentGreater Los Angeles Area
  3. Senseye, Inc.Board Membercurrent2026 — present
  4. EssenviaBoard Membercurrent2023 — present
  5. Strados LabsBoard Observercurrent2022 — present
  6. UCLA Anderson School of ManagementLecturer and Researcher2021 — 2023Los Angeles Metropolitan Area
  7. Implant DirectVice President Regulatory Affairs Quality Assurance2015 — 2017Greater Los Angeles Area
  8. Danaher CorporationDirector, Strategic Regulatory Affairs2014 — 2015Washington D.C. Metro Area
  9. FDADeputy Director2009 — 2014
  10. FDABranch Chief2006 — 2009
  11. FDABiomedical Engineer2002 — 2006

Skills & more

Public Speaking78Strategy99Leadership99Management62Strategic Planning17Board Administration10Treasury Services10Medical Devices99Start-ups55U.S. Food and Drug Administration (FDA)40Business Strategy46Early-stage Startups7
+1 moreExpert Witness

From Kwame's professional profile.

Investments

Investor

Essenvia

Per curated public sources.

Colleagues at Wavemaker Three-Sixty Health

Anne Dordai
Head of Portfolio and Platform at Wavemaker Three-Sixty Health
Brian Kadota
Director of Venture Operations at Wavemaker Three-Sixty Health
Bud Lawrence
Venture Partner at Wavemaker Three-Sixty Health
Dan Hirschfeld
Post-Acute Care at Wavemaker Three-Sixty Health
Emily Ah Sing
Fund Administration at Wavemaker Three-Sixty Health
Eric Marton
Senior Fund Advisor at Wavemaker Three-Sixty Health
Glenn Marshak
Hospital & Behavioral Health at Wavemaker Three-Sixty Health
Harlan Lavine
Health Innovation & Policy at Wavemaker Three-Sixty Health

Network1

Eric Marton
Senior Fund Advisor at Wavemaker Three-Sixty Health

Investors connected to Kwame in public investor directories — a warm-intro map.

Frequently asked questions

Who is Kwame Ulmer?
Kwame Ulmer is a Venture Partner focused on med-tech. He previously held progressive leadership roles at the FDA, including Deputy Director, and served as Vice President at a Danaher Corporation operating company, evaluating over 1,000 FDA applications. He is also Managing Partner at MedTech Impact Partners, founder of MedTech Color, and a lecturer who co-leads med-tech innovation research at UCLA's Anderson School of Management.
Where does Kwame Ulmer work?
Kwame Ulmer is Venture Partner at Wavemaker Three-Sixty Health.
What does Kwame Ulmer invest in?
Kwame Ulmer invests in Digital Health, Healthtech, Medical Devices.
What check size does Kwame Ulmer write?
Kwame Ulmer typically writes checks of $100K – $10M.
What companies has Kwame Ulmer invested in?
Investments tracked here include Essenvia.
Where did Kwame Ulmer go to school?
Kwame Ulmer studied at University of Virginia Darden School of Business (Master of Business Administration (M.B.A.)); University of Virginia (MS, Materials Engineering); Lincoln University (BS, Physics).

Same school

Shared employers